LRRC8D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.223600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.385800E-01
Normal-vs-Stage2
2.211600E-01
Normal-vs-Stage3
1.312020E-01
Normal-vs-Stage4
2.939400E-01
Stage1-vs-Stage2
8.510600E-01
Stage1-vs-Stage3
1.968220E-02
Stage1-vs-Stage4
3.522600E-01
Stage2-vs-Stage3
8.034400E-02
Stage2-vs-Stage4
2.112600E-01
Stage3-vs-Stage4
5.470200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.208000E-01
Normal-vs-AfricanAmerican
2.074600E-01
Normal-vs-Asian
1.903390E-01
Caucasian-vs-AfricanAmerican
2.391600E-01
Caucasian-vs-Asian
3.672400E-01
AfricanAmerican-vs-Asian
1.760360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.095800E-01
Normal-vs-Female
2.403200E-01
Male-vs-Female
1.777040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.219800E-01
Normal-vs-Age(41-60Yrs)
2.612200E-01
Normal-vs-Age(61-80Yrs)
2.065200E-01
Normal-vs-Age(81-100Yrs)
2.083400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.373600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.080200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.072600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.105900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.509400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.849010E-01
Normal-vs-Daily Drinker
1.951850E-01
Normal-vs-Weekly Drinker
1.682040E-01
Normal-vs-Occasional Drinker
6.172400E-02
Normal-vs-Social Drinker
1.837650E-02
Non Drinker-vs-Daily Drinker
7.783800E-01
Non Drinker-vs-Weekly Drinker
5.452200E-01
Non Drinker-vs-Occasional Drinker
2.800400E-02
Non Drinker-vs-Social Drinker
1.334850E-01
Daily Drinker-vs-Weekly Drinker
4.338200E-01
Daily Drinker-vs-Occasional Drinker
7.449500E-02
Daily Drinker-vs-Social Drinker
2.502600E-01
Weekly Drinker-vs-Occasional Drinker
3.057500E-02
Weekly Drinker-vs-Social Drinker
8.042000E-02
Occasional Drinker-vs-Social Drinker
5.124400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.861700E-02
Normal-vs-Grade 2
1.165780E-02
Normal-vs-Grade 3
2.216300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.579200E-01
Grade 1-vs-Grade 3
9.634800E-01
Grade 1-vs-Grade 4
7.861700E-02
Grade 2-vs-Grade 3
2.758600E-01
Grade 2-vs-Grade 4
1.165780E-02
Grade 3-vs-Grade 4
2.216300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.335700E-03
Normal-vs-NonDiabetic
2.116400E-01
Diabetic-vs-NonDiabetic
9.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.352000E-02
Normal-vs-NoPancreatitis
2.183600E-01
Pancreatitis-vs-NoPancreatitis
6.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.235600E-01
Normal-vs-N1
2.234200E-01
N0-vs-N1
9.610200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.850000E-01
Normal-vs-TP53-NonMutant
3.427600E-01
TP53-Mutant-vs-TP53-NonMutant
1.975390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
